1. The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling
- Author
-
Vladimir Berezin, Elisabeth Bock, Giuseppe Viale, Luigi Maddaluno, Raffaella Giavazzi, Lorenzo Bombardelli, Marco Bianchi, Giovanni Aletti, Chiara Casadio, Silvia Zecchini, Ugo Cavallaro, Giovanni Mazzarol, Alessandra Decio, Nicoletta Colombo, Fabio Sanguineti, Zecchini, S, Bombardelli, L, Decio, A, Bianchi, M, Mazzarol, G, Sanguineti, F, Aletti, G, Maddaluno, L, Berezin, V, Bock, E, Casadio, C, Viale, G, Colombo, N, Giavazzi, R, and Cavallaro, U
- Subjects
endocrine system diseases ,MED/40 - GINECOLOGIA E OSTETRICIA ,Cell ,Biology ,Fibroblast growth factor ,Mice ,neural cell adhesion molecule ,Cell Movement ,Ovarian carcinoma ,medicine ,Animals ,Humans ,Neoplasm Invasiveness ,Receptor, Fibroblast Growth Factor, Type 1 ,signalling ,Neoplasm Metastasis ,Neural Cell Adhesion Molecules ,Neoplasm Invasivene ,Ovarian Neoplasms ,Animal ,Ovarian Neoplasm ,Carcinoma ,Cell migration ,medicine.disease ,Immunohistochemistry ,female genital diseases and pregnancy complications ,Cell biology ,ovarian carcinoma ,Disease Models, Animal ,medicine.anatomical_structure ,nervous system ,Fibroblast growth factor receptor ,fibroblast growth factor receptor ,tumour progression ,Molecular Medicine ,Female ,Neural cell adhesion molecule ,Signal transduction ,Ovarian cancer ,Human ,Research Article ,Signal Transduction - Abstract
Epithelial ovarian carcinoma (EOC) is an aggressive neoplasm, which mainly disseminates to organs of the peritoneal cavity, an event mediated by molecular mechanisms that remain elusive. Here, we investigated the expression and functional role of neural cell adhesion molecule (NCAM), a cell surface glycoprotein involved in brain development and plasticity, in EOC. NCAM is absent from normal ovarian epithelium but becomes highly expressed in a subset of human EOC, in which NCAM expression is associated with high tumour grade, suggesting a causal role in cancer aggressiveness. We demonstrate that NCAM stimulates EOC cell migration and invasion in vitro and promotes metastatic dissemination in mice. This pro-malignant function of NCAM is mediated by its interaction with fibroblast growth factor receptor (FGFR). Indeed, not only FGFR signalling is required for NCAM-induced EOC cell motility, but targeting the NCAM/FGFR interplay with a monoclonal antibody abolishes the metastatic dissemination of EOC in mice. Our results point to NCAM-mediated stimulation of FGFR as a novel mechanism underlying EOC malignancy and indicate that this interplay may represent a valuable therapeutic target. © 2011 EMBO Molecular Medicine.
- Published
- 2011